Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Webinars
visit N-Site
visit the Taylor Wessing Patent Map
visit Global Data Hub

SPC manufacturing waiver (Part 3): Notification obligations – Information is power

 

In their third article on the new SPC manufacturing waiver, Verena Bertram and Anja Lunze examine the information obligations under the MW-Regulation and their consequences.

 

arrowView our previous articles

Topical Issues

 

Territorial licensing: "start at the end before you begin" - Colin McCall and Justyna Ostrowska explain how territorial licences can be a great way to get your product on the market, and why it's still not enough to sign off the rights and wait for the royalties to come in....read more

 

Too sweet to throw away? Sweetened/carbonated beverages industry law changes in Poland - Agata Głowinkowska and Agnieszka Sztoldman explain important new rules for the food and beverage industry in Poland....
read more

 

Arbitration for life sciences companies - Laurence Lieberman, Tasmina Goraya and Colin McCall set out some of the reasons why arbitration can be an attractive alternative for life sciences companies when resolving their contract disputes....read more

 

Impact of COVID-19 on venture-backed biotech companies - Josef Fuss, Adrian Toutoungi and Matthew Caskie examine how life sciences companies have experienced a considerable operational impact as a result of the pandemic, which has led to the pausing of a significant percentage of clinical trials....read more

 

Legal advice privilege: where are we now? - Georgina Jones and Iona Macmillan Douglas review the Court of Appeal's important decision on privilege in Jet2.com v Civil Aviation Authority and provide some practical steps that businesses can take to protect their communications....read more

 

Patents diary June 2020: UK Supreme Court holds Regeneron's transgenic mice patents invalid - Paul England explains the meaning and effect of the Supreme Court decision in the Regeneron v Kymab transgenic mouse case....
read more

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector.
Register here